NYLIM
MIRM icon

New York Life Investment Management’s Mirum Pharmaceuticals MIRM Stock Holding History

New York Life Investment Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-14,309
Closed -$359K – 1142
2024
Q1 		$359K Buy
+14,309
New +$393K ﹤0.01% 1221

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

New York Life Investment Management's MIRM Position: Q2 2024 in Review

New York Life Investment Management sold out of Mirum Pharmaceuticals (MIRM) in Q2 2024, closing a stake of 14,309 shares — an estimated $359K sold.

New York Life Investment Management first reported a position in MIRM in Q1 2024 and held it in 1 quarter. The position peaked at $359K in Q1 2024. 160 funds tracked by Wall St. Rank hold MIRM as of Q2 2024.

  • New York Life Investment Management reported no remaining Mirum Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • New York Life Investment Management sold 14,309 Mirum Pharmaceuticals shares in Q2 2024, an estimated $359K.
  • New York Life Investment Management first reported a position in Mirum Pharmaceuticals in Q1 2024 and held it in 1 quarter.
  • New York Life Investment Management's Mirum Pharmaceuticals position peaked at $359K in Q1 2024.
  • 160 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2024.

Based on New York Life Investment Management's 13F filing for Q2 2024, filed 5 Aug 2024.